Hematuria Clinical Trials

7 recruiting

Hematuria Trials at a Glance

10 actively recruiting trials for hematuria are listed on ClinicalTrialsFinder across 6 cities in 6 countries. The largest study group is Not Applicable with 4 trials, with the heaviest enrollment activity in London, Dallas, and Chicago. Lead sponsors running hematuria studies include Erasmus Medical Center, Northwestern University, and British Urology Researchers in Surgical Training.

Browse hematuria trials by phase

Treatments under study

About Hematuria Clinical Trials

Looking for clinical trials for Hematuria? There are currently 7 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Hematuria trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Hematuria clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 110 of 10 trials

Recruiting
Not Applicable

Bladder Cancer Screening Trial

Urothelial CarcinomaBladder CancerSmoking Cessation+1 more
University of Texas Southwestern Medical Center1,000 enrolled1 locationNCT05646485
Recruiting

A Study of Ward Admissions for Haematuria

Urothelial CarcinomaBladder CancerRenal Cancer+3 more
British Urology Researchers in Surgical Training1,050 enrolled1 locationNCT07395037
Recruiting

Bladder EpiCheck European Haematuria Study

Urothelial Carcinoma BladderUrothelial Carcinoma of the Renal Pelvis and UreterHematuria+2 more
Nucleix Ltd.800 enrolled5 locationsNCT06818136
Recruiting
Not Applicable

Pain Type and Interstitial Cystitis/Bladder Pain Syndrome Treatment

Chronic ProstatitisInterstitial CystitisBladder Pain Syndrome+8 more
Vanderbilt University Medical Center220 enrolled1 locationNCT06299683
Recruiting

Causes and Management of Children Presenting With Macroscopic Hematuria in the Pediatric Emergency Department

Macroscopic Hematuria
University Hospital, Strasbourg, France100 enrolled1 locationNCT07312461
Recruiting

Women With isoLated acUte cyStitis and Macroscopic Hematuria. Is Further Investigation Needed?

Urothelial CarcinomaBladder CancerRenal Cancer+2 more
Vastra Gotaland Region300 enrolled1 locationNCT07037589
Recruiting
Not Applicable

Study to Assess the Impact of the Urine Test Cxbladder Triage Plus on the Number of Cystoscopies Performed on Patients With Invisible Blood in Their Urine.

Hematuria - Cause Not Known
Pacific Edge Limited1,000 enrolled15 locationsNCT06394869
Recruiting

Alport Therapy Registry - European Initiative Towards Delaying Renal Failure in Alport Syndrome

Alport SyndromePediatric Kidney DiseaseThin Basement Membrane Disease+2 more
University Hospital Goettingen800 enrolled1 locationNCT02378805
Recruiting
Phase 3

Intra-operative Loop Diuretics to Improve Same-day Discharge Rates After HoLEP

HematuriaSame Day DischargeBPH+1 more
Northwestern University138 enrolled1 locationNCT05620784
Recruiting
Not Applicable

Safely Reduce Cystoscopic Evaluations for Hematuria Patients

Urothelial CarcinomaBladder CancerHematuria+1 more
Erasmus Medical Center1,100 enrolled1 locationNCT06026189